University of Plymouth
Plymouth, Devon, PL4 8AA, United Kingdom
Location status: Recruiting
Location contact
Patricia Casas, PhD
CONTACT
Raul Bescos, PhD
CONTACT
NCT Number: NCT07172009
The digestion of carbohydrates begins in the mouth through the salivary enzyme amylase which breaks food starches into maltose and disaccharides. The mouth also has a large community of microorganisms which include bacteria, fungi, viruses and protozoa that can also assist in the digestion of carbohydrates. Mouthwashes containing antibacterial compounds such as chlorhexidine are used to kill oral bacteria, but current evidence indicates that a majority of these bacteria are essential for human health.
The aim of this study is to investigate whether chlorhexidine mouthwash can also affect the digestion of carbohydrates. At least 25 individuals will be recruited. Participants will visit the laboratory in two occasions. A saliva and blood sample (fingertip to measure blood glucose) will be taken at baseline. Then, using a randomized, cross-over and double-blind design, the participants will rinse their mouth for two minutes with a placebo or chlorhexidine mouthwash. Then, participants will eat 50 g of white bread and blood glucose will be measured (fingertips) every 30 min for the following 2 hours. Another saliva sample will be collected at the end of each test.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Plymouth, Devon, PL4 8AA, United Kingdom
Location status: Recruiting
Patricia Casas, PhD
CONTACT
Raul Bescos, PhD
CONTACT
Blood glucose is measured at baseline and following food intake using a blood glucose meter (ACCU-CHEK Performa, Roche, USA). Participants are then provided with 10 mL of the assigned mouthwash according to randomisation. Mouthwashes are blinded for both researchers and participants, as they are prepared by an external individual, covered, and labelled with group numbers. This ensures that neither participants nor researchers can identify the treatment allocation.
Oral rinsing is performed for 2 minutes before participants spit out the mouthwash. The mouthwashes used include:
Chlorhexidine di-gluconate (0.2%) (Corsodyl, GlaxoSmithKline, England) Placebo (water with yellow food colouring)
Following the mouth rinse, participants consume a pre-weighed breakfast meal consisting of 40 g of Hubbard's Foodstore® strawberry jam (Sainsbury's Supermarkets Ltd., London, UK) spread over 50 g of soft white bread (Sainsbury's Supermarkets Ltd., Northern Ireland, UK).
Blood glucose measurements are taken at 15, 30, 45, 60, 90, and 120 minutes post-meal.Baseline blood glucose values are used as reference points. For analysis, only the differences between baseline and subsequent time-point measurements are considered. The mean iAUC is calculated for each mouthwash condition (chlorhexidine and placebo).
Each participant completes the protocol twice, once for each mouthwash condition, with a minimum washout period of 48 hours between sessions.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Healthy adults (> 18 years/old)
Exclusion criteria
The main exclusion criteria is pregnancy, people following cancer treatment, taking immunosuppressant or antibiotics and using antibacterial mouthwash for less than 2 weeks before the study.
Rinsing the mouth with chlorhexidine mouthwash for 2 minutes before consuming 50 g of carbohydrates
Rinsing the mouth with placebo mouthwash for 2 minutes before consuming 50 g of carbohydrates
Time frame: 2 hours
Contact information is provided by the study sponsor or research team.
Raul Bescos Garcia
CONTACT
Zoe Brookes
CONTACT
University of Plymouth
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06575426
Autoimmune Diseases, Diabetes Mellitus
Chicago, Illinois, United States
View Trial DetailsNCT05910840
Autoimmune Diseases, Diabetes Mellitus
Gatineau, Canada
View Trial DetailsNCT04201600
Aging, Behavior
Baltimore, Maryland, United States
View Trial DetailsNCT06334172
Glucose Metabolism Disorders, Glucose Metabolism Disorders (Including Diabetes Mellitus)
Hellerup, Capital Region, Denmark
View Trial Details